Superior Genomics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-14.
Superior Genomics, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 14, 2026. The filing reports $508K sold. Its industry group is Other Technology. It names David Van Holla (Executive Officer, Director), John Freshley (Director) (SEC Form D, August 14, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Superior Genomics, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Superior Genomics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-08-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Superior Genomics, Inc.
Free to see. No signup.
More on the people and the money behind Superior Genomics, Inc., from the filings we hold.
Other Technology raises by companies based in Michigan, filed in August 2026, largest first.
Get an email when Superior Genomics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Superior Genomics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Superior Genomics, Inc. →Get the full cited report on Superior Genomics, Inc.
What the filing shows about Superior Genomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Superior Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Superior Genomics, Inc.'s address as 640 Main St, Norway, MI 49870.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Superior Genomics, Inc. See pricing
Superior Genomics, Inc. is a registered filer with the SEC (CIK 2148532) and has filed since 2026-08-14. 1 filing is on record, the latest on 2026-08-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Superior Genomics, Inc.'s Form D of 2026-08-14 names David Van Holla and John Freshley as its officers, directors or promoters.
Its new offerings report $508K sold across 1 offering, as its own filings state.
Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $508K, on the same scale — one filing against the whole group's total, so it sits low by construction.
David Van Holla is named as Executive Officer and Director on the Form D that Superior Genomics, Inc. filed with the SEC on 14 August 2026, one of 2 people that filing names.
John Freshley is named as Director on the Form D that Superior Genomics, Inc. filed with the SEC on 14 August 2026, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2026-08-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Superior Genomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Superior Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Superior Genomics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Superior Genomics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Superior Genomics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Superior Genomics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-08-10 · AI and software raises, week of 2026-08-10
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/superior-genomics-inc-form-d-26000001